8-K:重大事件
8-K:重大事件
8-K:重大事件
8-K:重大事件
NT 10-Q:季报延迟披露公告
8-K:重大事件
Ocean Biomedical | 10-Q:季度报表
Ocean Biomedical | 10-Q/A:季度报表(修正版)
Ocean Biomedical | 10-Q/A:季度报表(修正版)
Ocean Biomedical | NT 10-K:其他
Ocean Biomedical | 8-K:重大事件
Ocean Biomedical | 8-K:重大事件
Ocean Biomedical | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-Lighthouse Investment Partners, LLC(0%),MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC(0%)等
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-ATW SPAC MANAGEMENT LLC(0.0%),Antonio Ruiz-Gimenez(0.0%)
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-Boothbay Fund Management, LLC(0%),Boothbay Absolute Return Strategies LP(0%)等
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-FTCS Sub GP LLC(0%)
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-Polar Asset Management Partners Inc.(7.7%)
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-Saba Capital Management, L.P.(0%),Boaz R. Weinstein(0%)等
Ocean Biomedical | SC 13G/A:超过5%持股股东披露文件(修正)-ANDREW M. WEISS, PH.D.(0.00%)
暂无数据
暂无数据